Thursday, December 12, 2024
- Advertisement -spot_img

TAG

challengesat

Granules India faces US FDA inspection challenges at Gagillapur facility

Pharmaceutical manufacturer Granules India Limited disclosed today that its Gagillapur facility in Hyderabad has been classified as “Official Action Indicated” (OAI) by the...

Latest news

- Advertisement -spot_img